TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/20 16:44 | 1/24/20 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Mayer Eldon C. III | CA | O | Ex VP,Ch | P | 68 | 13.52 | 0 | 5 | 20 | 30 | D | |||||||||||||||
11/30/18 14:26 | 11/29/18 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Mayer Eldon C. III | CA | D | P | 41 | 10.21 | 0 | 4 | 19 | 25 | D | ||||||||||||||||
11/28/18 20:51 | 11/26/18 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Mayer Eldon C. III | CA | D | P.m | 208 | 9.90 | 0 | 21 | New | 21 | D | ||||||||||||||||
9/12/18 19:48 | 9/10/18 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mayer Eldon C. III | CA | O | EVP,Chie | P.m | 326 | 3.26 | 0 | 100 | 87 | 215 | D | ||||||||||||||
8/27/18 19:49 | 8/23/18 | RIGL | Rigel Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mayer Eldon C. III | CA | O | EVP,Chie | P | 282 | 2.82 | 0 | 100 | 667 | 115 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |